Science Change In Cash vs Free Cash Flow Analysis
SAIC Stock | USD 123.91 0.90 0.73% |
Science Applications financial indicator trend analysis is much more than just breaking down Science Applications prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Science Applications is a good investment. Please check the relationship between Science Applications Change In Cash and its Free Cash Flow accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Change In Cash vs Free Cash Flow
Change In Cash vs Free Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Science Applications Change In Cash account and Free Cash Flow. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Science Applications' Change In Cash and Free Cash Flow is 0.1. Overlapping area represents the amount of variation of Change In Cash that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Science Applications International, assuming nothing else is changed. The correlation between historical values of Science Applications' Change In Cash and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change In Cash of Science Applications International are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Change In Cash i.e., Science Applications' Change In Cash and Free Cash Flow go up and down completely randomly.
Correlation Coefficient | 0.1 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Change In Cash
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Most indicators from Science Applications' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Science Applications current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At present, Science Applications' Enterprise Value Over EBITDA is projected to drop based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 13.87, whereas Selling General Administrative is forecasted to decline to about 234.2 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 105M | 120M | 138M | 86.4M | Depreciation And Amortization | 165M | 157M | 142M | 110.4M |
Science Applications fundamental ratios Correlations
Click cells to compare fundamentals
Science Applications Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Science Applications fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 59M | 58.7M | 58.1M | 55.8M | 53.7M | 101.4M | |
Total Assets | 4.7B | 5.7B | 5.7B | 5.5B | 5.3B | 4.7B | |
Short Long Term Debt Total | 2.1B | 2.7B | 2.7B | 2.5B | 2.2B | 1.9B | |
Other Current Liab | 203M | 690M | 592M | 471M | 514M | 387.7M | |
Total Current Liabilities | 1.1B | 1.3B | 1.4B | 1.1B | 1.2B | 950.5M | |
Total Stockholder Equity | 1.4B | 1.5B | 1.6B | 1.7B | 1.8B | 1.4B | |
Property Plant And Equipment Net | 281M | 344M | 309M | 250M | 243M | 225.2M | |
Current Deferred Revenue | 41M | 82M | 55M | 48M | 43.2M | 51.9M | |
Net Debt | 1.9B | 2.5B | 2.6B | 2.4B | 2.2B | 1.4B | |
Retained Earnings | 506M | 627M | 818M | 1.0B | 1.4B | 1.5B | |
Accounts Payable | 814M | 517M | 612M | 624M | 567M | 459.8M | |
Cash | 188M | 171M | 106M | 109M | 94M | 89.3M | |
Non Current Assets Total | 3.3B | 4.4B | 4.5B | 4.3B | 4.2B | 2.8B | |
Non Currrent Assets Other | (153M) | (192M) | 129M | (243M) | 167M | 175.4M | |
Cash And Short Term Investments | 188M | 171M | 106M | 109M | 94M | 89.3M | |
Net Receivables | 1.1B | 962M | 1.0B | 936M | 914M | 864.1M | |
Good Will | 2.1B | 2.8B | 2.9B | 2.9B | 2.9B | 1.9B | |
Liabilities And Stockholders Equity | 4.7B | 5.7B | 5.7B | 5.5B | 5.3B | 4.7B | |
Non Current Liabilities Total | 2.2B | 2.9B | 2.8B | 2.7B | 2.4B | 1.9B | |
Inventory | 146M | 143M | 156M | 142M | 3M | 2.9M | |
Other Current Assets | 25M | 19M | 78M | 81M | 120M | 126M | |
Other Stockholder Equity | 984M | 1.0B | 838M | 637M | 337M | 513.7M | |
Total Liab | 3.3B | 4.2B | 4.1B | 3.8B | 3.5B | 3.3B | |
Property Plant And Equipment Gross | 281M | 344M | 309M | 250M | 427M | 239.6M | |
Total Current Assets | 1.4B | 1.3B | 1.3B | 1.2B | 1.1B | 1.4B | |
Accumulated Other Comprehensive Income | (72M) | (89M) | (37M) | 22M | 16M | 16.8M | |
Short Term Debt | 70M | 68M | 148M | 31M | 77M | 65.4M | |
Intangible Assets | 711M | 1.1B | 1.1B | 1.0B | 894M | 540.0M | |
Other Liab | 102M | 133M | 244M | 203M | 233.5M | 245.1M | |
Other Assets | 100M | 123M | 138M | 129M | 148.4M | 155.8M | |
Long Term Debt | 1.9B | 2.4B | 2.4B | 2.3B | 2.0B | 1.4B | |
Property Plant Equipment | 91M | 344M | 309M | 92M | 105.8M | 119.9M | |
Net Tangible Assets | (1.3B) | (2.4B) | (2.4B) | (2.1B) | (1.9B) | (2.0B) | |
Retained Earnings Total Equity | 506M | 627M | 818M | 1.0B | 1.2B | 1.2B | |
Long Term Debt Total | 1.9B | 2.4B | 2.4B | 2.3B | 2.7B | 1.7B | |
Capital Surpluse | 983M | 1.0B | 838M | 637M | 732.6M | 670.1M | |
Non Current Liabilities Other | 133M | 244M | 160M | 218M | 174M | 118.3M | |
Common Stock | 1.5B | 1.4B | 1.6B | 1.7B | 1.9B | 2.0B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Science Applications offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Science Applications' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Science Applications International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Science Applications International Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is IT Consulting & Other Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Applications. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Applications listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1.48 | Earnings Share 5.6 | Revenue Per Share 140.869 | Quarterly Revenue Growth 0.019 |
The market value of Science Applications is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Applications' value that differs from its market value or its book value, called intrinsic value, which is Science Applications' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Applications' market value can be influenced by many factors that don't directly affect Science Applications' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Science Applications' value and its price as these two are different measures arrived at by different means. Investors typically determine if Science Applications is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Applications' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.